北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 妇科肿瘤中心  > 期刊论文
学科主题: 临床医学
题名:
Construction, expression, and function of 6B11ScFv-mIL-12, a fusion protein that attacks human ovarian carcinoma
作者: Cheng, Hongyan1,2; Ye, Xue2; Chang, Xiaohong2; Ma, Ruiqiong2; Cong, Xu2; Niu, Yidong2; Zhang, Menglei2; Liu, Kai2; Cui, Heng2; Sang, Jianli1
关键词: Ovarian cancer ; Anti-idiotypic antibody ; Interleukin-12 ; 6B11 ; Fusion protein
刊名: MEDICAL ONCOLOGY
发表日期: 2015-04-01
DOI: 10.1007/s12032-015-0586-y
卷: 32, 期:4
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Oncology
研究领域[WOS]: Oncology
关键词[WOS]: NON-HODGKINS-LYMPHOMA ; 1E10 ANTIIDIOTYPE VACCINE ; CELL LUNG-CANCER ; PHASE-I TRIAL ; MONOCLONAL-ANTIBODY ; CARCINOEMBRYONIC ANTIGEN ; ANTITUMOR-ACTIVITY ; COLORECTAL-CANCER ; DENDRITIC CELLS ; IMMUNE-RESPONSE
英文摘要:

We previously produced an anti-idiotypic monoclonal antibody, 6B11, which mimics ovarian cancer antigen CA166-9 and induces cellular and humoral immunity. Here, to enhance the immunogenicity of 6B11, we constructed the 6B11ScFv-mIL-12 fusion protein (FP), by fusing single-chain fragment of 6B11 variable region (6B11ScFv) with mouse interleukin-12 (mIL-12), which was expressed in eukaryotic 293EBNA cells transfected with pSBI vectors. A binding activity assay showed 6B11ScFv-mIL-12 to have activities of both 6B11 and mIL-12-it specifically bound both ovarian monoclonal antibody COC166-9 and rabbit anti-mouse IL-12 antibody. The immune activity assay showed 6B11ScFv-mIL-12 to promote proliferation of lymphocytes stimulated by phytohemagglutinin, increase the absolute numbers and percentages of CD3(-)/CD56(+) natural killer cells and CD3(+)/CD56(+) natural killer T cells among peripheral lymphocytes, and increase interferon-gamma. The FP was specifically cytotoxic to the CA166-9(+) ovarian cancer cell lines HOC1A and SKOV3 and inhibited growth of ID8 subcutaneous tumors in C57BL/6J mice. This study provides an experimental basis for clinical use of 6B11ScFv-mIL-12 in ovarian cancer therapy. To our knowledge, this is the first report of a fusion protein from an anti-idiotypic antibody and IL-12.

语种: 英语
所属项目编号: 30901748 ; 2012AA02A507
项目资助者: National Natural Science Foundation of China (NSFC) ; National High Technology Research and Development Program (863 Program)
WOS记录号: WOS:000351474100044
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/57537
Appears in Collections:北京大学第二临床医学院_妇科肿瘤中心_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Beijing Normal Univ, Coll Life Sci, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China
2.Peking Univ, Gynecol Oncol Ctr, Peoples Hosp, Beijing 100044, Peoples R China

Recommended Citation:
Cheng, Hongyan,Ye, Xue,Chang, Xiaohong,et al. Construction, expression, and function of 6B11ScFv-mIL-12, a fusion protein that attacks human ovarian carcinoma[J]. MEDICAL ONCOLOGY,2015,32(4).
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Cheng, Hongyan]'s Articles
[Ye, Xue]'s Articles
[Chang, Xiaohong]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Cheng, Hongyan]‘s Articles
[Ye, Xue]‘s Articles
[Chang, Xiaohong]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace